FDMT – 4d molecular therapeutics, inc. (US:NASDAQ)
Stock Stats
News
4D Molecular Therapeutics (NASDAQ:FDMT) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
4DMT Provides Company Update and Anticipated Development Milestones for 2026
Why Everyone Is Watching 4D Molecular Therapeutics, Inc. (FDMT) Closely [Yahoo! Finance]
4D Molecular Therapeutics: Jury Still Out On CF Gene Therapy After Dense Data Drop [Seeking Alpha]
4D Molecular Therapeutics (NASDAQ:FDMT) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $26.00 price target on the stock.
Form 4 4D Molecular Therapeutic For: Jan 05 Filed by: SBLENDORIO GLENN
Form 3 4D Molecular Therapeutic For: Jan 05 Filed by: SBLENDORIO GLENN
Form 8-K 4D Molecular Therapeutic For: Dec 31
Form 4 4D Molecular Therapeutic For: Dec 20 Filed by: Gupta Ashoo
Form 3 4D Molecular Therapeutic For: Dec 09 Filed by: Simms Christopher Paul
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.